Practical combination therapy of Amlodin and angiotensin II Receptor blocker(ARB); safety and efficacy in paTieNts with hypERtension Study (PARTNER Study)
Not Applicable
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000005888
- Lead Sponsor
- Dainippon Sumitomo Pharma Co.,Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6000
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Hypertensive Patients who had already received antihypertensive combination therapy with both Amlodin and ARB,and ARB-amlodipine combination agent, before the enrollment (2)Hypertensive patients who have received amlodipine preparation except Amlodin within 12 weeks of the enrollment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method